Basic Research Powers the First Medication for Postpartum Depression
Briefly

from National Institute of Mental Health (NIMH)2 weeks ago
In 2019, brexanolone-a medication that acts by mimicking allopregnanolone-became the first approved drug to treat PPD.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/news/science-news/2024/basic-research-powers-the-first-medication-for-postpartum-depression
More than the blues: Impacts of PPD on women's mental health. Rates of depression are high among postpartum women, affecting 1 in 8 with symptoms.
National Institute of Mental Health (NIMH)https://www.nimh.nih.gov/news/science-news/2024/basic-research-powers-the-first-medication-for-postpartum-depression
Read at National Institute of Mental Health (NIMH)
#postpartum-depression #allopregnanolone #brexanolone #mental-health #depression-treatment
[
add
]
[
|
|
]